Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-08
1999-06-29
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514277, 514344, 514352, 514355, 546286, 546290, 546291, 546304, A61K 3144
Patent
active
059169052
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating inflammation and inflammation-associated disorders, such as arthritis.
BACKGROUND OF THE INVENTION
Prostaglandins play a major role in the inflammation process and the inhibition of prostaglandin production, especially production of PGG.sub.2, PGH.sub.2 and PGE.sub.2, has been a common target of antiinflammatory drug discovery. However, common non-steroidal antiinflammatory drugs (NSAIDs) that are active in reducing the prostaglandin-induced pain and swelling associated with the inflammation process are also active in affecting other prostaglandin-regulated processes not associated with the inflammation process. Thus, use of high doses of most common NSAIDs can produce severe side effects, including life threatening ulcers, that limit their therapeutic potential. An alternative to NSAIDs is the use of corticosteroids, which have even more drastic side effects, especially when long term therapy is involved.
Previous NSAIDs have been found to prevent the production of prostaglandins by inhibiting enzymes in the human arachidonic acid/prostaglandin pathway, including the enzyme cyclooxygenase (COX). The recent discovery of an inducible enzyme associated with inflammation (named "cyclooxygenase-2 (COX-2)" or "prostaglandin G/H synthase II") provides a viable target of inhibition which more effectively reduces inflammation and produces fewer and less drastic side effects.
The references below that disclose antiinflammatory activity, show continuing efforts to find a safe and effective antiinflammatory agent. The novel pyridines disclosed herein are such safe and also effective antiinflammatory agents furthering such efforts. The invention's compounds are found to show usefulness i vivo as antiinflammatory agents with minimal side effects. The substituted pyridinyl compounds disclosed herein preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1.
Pyridines have been described for various uses, including the treatment of inflammation. U.S. Pat. No. 5,225,418 to Miller, describes 4-(1H)-quinolinones as intermediates in the preparation of antiinflammatory agents.
European Application, EP388,619, published Sep. 26, 1990, describes a method of preparing pyridine-2,3-dicarboxylic acids.
European Application, EP308,020, published Mar. 22, 1989, describes 1,2-dihydro-2-oxo-3-pyridylcarboxylic acids as having antibiotic activity. 3-carboxylic acid is specifically described.
U.S. Pat. No. 3,655,679, to Shen et al, describes aryl pyridine carboxylic acids as having antiinflammatory activity.
British Pat. No. 1,238,959 describes pyridyl derivatives as having antiinflammatory activity. Specifically, 4-(2-1H-pyridon-3-yl)benzenesulfonamide is described.
U.S. Pat. No. 4,011,328, to Pinhas et al, describes derivatives of pyridine-3-acetic acid as having antiinflammatory properties. dyl!acetic acid is described. U.S. Pat. No. 4,533,666, to Matsumoto et al, describes 6-phenyl-2,3-(4-methoxyphenyl)pyridine derivatives as having antiinflammatory properties.
The invention's pyridyl compounds are found to show usefulness in vivo as antiinflammatory agents with minimal side effects.
DESCRIPTION OF THE INVENTION
A class of substituted pyridyl compounds useful in treating inflammation-related disorders is defined by Formula I: ##STR1## wherein R.sup.1 is selected from hydrido, halo, alkyl, haloalkyl, alkoxy, haloalkoxy, aryl, alkylthio, alkylamino, aralkoxy, aralkylthio, aralkylamino, N-alkyl-N-aralkylamino, heteroaralkoxy, heteroaralkylthio, heteroaralkylamino, N-alkyl-N-heteroaralkylamino, cycloalkylalkoxy, cycloalkyialkylthio, N-alkyl-N-cycloalkylalkylamino, azido, arylcarbonylalkoxy, arylcarbonylthio, alkoxycarbonylalkoxy, alkylaminocarbonylalkoxy, alkoxycarbonylalkylthio, alkylaminocarbonylalkylthio, arylcarbonylalkylamino, alkoxycarbonylalkylamino, alkenylthio, alkenylamino, N-alkyl-N-alkenylamino, arylalkenyloxy and alkenyloxy; aminoalkyl
Koszyk Francis J
Lee Len F
Partis Richard A
Weier Richard M
Bulock Joseph W.
G. D. Searle & Co.
Owens Amelia
Williams Scott
LandOfFree
2,3-substituted pyridines for the treatment of inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3-substituted pyridines for the treatment of inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-substituted pyridines for the treatment of inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375652